Mayank Bansal is a CFA Charterholder and heads the Equity Research team at Kapitales Research, with over 5 years of experience analysing global equity markets. He leads fundamental, data-driven research combining rigorous financial analysis with macro trends.
3 ASX Stocks Gain as Shareholder Notices and Securities Changes Draw Attention
Source: Kapitales Research
Highlights:
One company reported that a major institutional investor ceased to be a substantial holder.
A medical imaging technology business disclosed the lapse of 5,000 performance rights.
A banking group reported the cessation of performance rights, deferred awards and expired options.
Three ASX-listed companies recorded gains in the share market, with their latest announcements covering changes to substantial shareholdings and employee-related securities. The disclosures, released on different dates in October 2026, provide updates on investor interests and changes to the companies’ issued securities. The share price movements listed below reflect the supplied market data and do not necessarily indicate that the announcements caused the gains.
Stocks in Focus
Generation Development Group Limited (ASX: GDG)rose AU$0.459, or 17.164%, to AU$3.140.
4DMedical Limited (ASX: 4DX)gained AU$0.280, or 7.368%, to AU$4.080.
Bank of Queensland Limited (ASX: BOQ) increased AU$0.379, or 5.855%, to AU$6.870.
Generation Development Group Reports Change in Substantial Holding
Generation Development Group Limited disclosed on 14 October 2026 that State Street Corporation and its subsidiaries had ceased to be substantial holders, effective 12 October 2026. The notice detailed changes in relevant interests involving ordinary shares, including transfers and securities-lending and collateral transactions. The filing also identified several State Street subsidiaries associated with the substantial holding. The notice records the change in the investor’s substantial-holder status; it does not, by itself, establish the reasons behind the change or indicate a broader shift in the company’s business outlook.
4DMedical Reports Lapse of Performance Rights
4DMedical Limited announced on 2 October 2026 that 5,000 unquoted performance rights had ceased, with the cessation recorded for 29 October 2026. According to the Appendix 3H filing, the rights lapsed because the relevant conditions had not been met or could no longer be satisfied. The company stated that no consideration was payable for the cessation. Following the change, the filing listed 601,591,047 ordinary shares on issue, alongside its other quoted and unquoted securities. The disclosure relates to equity incentives rather than a change to the company’s operating performance.
Bank of Queensland Discloses Securities Cessation
Bank of Queensland Limited released an Appendix 3H notice on 15 October 2026 covering several securities that had ceased. These included 314,675 performance rights, 4,944 deferred award rights and 2,950 CEO and chair award rights that lapsed on 30 September 2026 because their conditions were not satisfied or had become incapable of being met. The notice also recorded 1,014,518 premium-priced options that expired without exercise on 6 December 2025. The bank attributed the delayed processing of those options to an administrative delay and stated that it was satisfied with its systems and processes for securities transactions and related notifications.
Conclusion
The announcements provide separate updates on institutional shareholding status and equity securities for three ASX-listed businesses. Investors may monitor future company disclosures for additional information, while assessing share-price movements alongside broader market conditions and each company’s operating fundamentals.
Note- All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
3 ASX Stocks Gain as Shareholder Notices and Securities Changes Draw Attention
Highlights:
Three ASX-listed companies recorded gains in the share market, with their latest announcements covering changes to substantial shareholdings and employee-related securities. The disclosures, released on different dates in October 2026, provide updates on investor interests and changes to the companies’ issued securities. The share price movements listed below reflect the supplied market data and do not necessarily indicate that the announcements caused the gains.
Stocks in Focus
Generation Development Group Reports Change in Substantial Holding
Generation Development Group Limited disclosed on 14 October 2026 that State Street Corporation and its subsidiaries had ceased to be substantial holders, effective 12 October 2026. The notice detailed changes in relevant interests involving ordinary shares, including transfers and securities-lending and collateral transactions. The filing also identified several State Street subsidiaries associated with the substantial holding. The notice records the change in the investor’s substantial-holder status; it does not, by itself, establish the reasons behind the change or indicate a broader shift in the company’s business outlook.
4DMedical Reports Lapse of Performance Rights
4DMedical Limited announced on 2 October 2026 that 5,000 unquoted performance rights had ceased, with the cessation recorded for 29 October 2026. According to the Appendix 3H filing, the rights lapsed because the relevant conditions had not been met or could no longer be satisfied. The company stated that no consideration was payable for the cessation. Following the change, the filing listed 601,591,047 ordinary shares on issue, alongside its other quoted and unquoted securities. The disclosure relates to equity incentives rather than a change to the company’s operating performance.
Bank of Queensland Discloses Securities Cessation
Bank of Queensland Limited released an Appendix 3H notice on 15 October 2026 covering several securities that had ceased. These included 314,675 performance rights, 4,944 deferred award rights and 2,950 CEO and chair award rights that lapsed on 30 September 2026 because their conditions were not satisfied or had become incapable of being met. The notice also recorded 1,014,518 premium-priced options that expired without exercise on 6 December 2025. The bank attributed the delayed processing of those options to an administrative delay and stated that it was satisfied with its systems and processes for securities transactions and related notifications.
Conclusion
The announcements provide separate updates on institutional shareholding status and equity securities for three ASX-listed businesses. Investors may monitor future company disclosures for additional information, while assessing share-price movements alongside broader market conditions and each company’s operating fundamentals.
Note- All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au